image credit: Unsplash

CDC eyes safety of J&J COVID jab as EU backs booster

December 16, 2021


A Centres for Disease and Control Prevention (CDC) advisory committee is scheduled to meet today to discuss the new results, according to a Washington Post report, which point to continued rates of blood clots among people taking the vaccine.

The single-dose adenoviral shot – much like the AstraZeneca/Oxford University vaccine – has been linked to rare cases of a rare and severe type of blood clot. There have been more cases in young and middle-aged women, which the Post said will be discussed at today’s meeting.

Read More on Pharmaphorum